AtriCure, Inc. Operating Income Loss

• AtriCure, Inc. showed an increase of +76.4% in Operating Income Loss from 2024 to 2025.
• This data is from AtriCure, Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
• XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 17 years of available data (2009 to 2025), AtriCure, Inc.'s Operating Income Loss has grown by 39.1%.
• Historical annual values: Fiscal year 2025: -$9.45 million | Fiscal year 2024: -$40.01 million | Fiscal year 2023: -$26.68 million | Fiscal year 2022: -$42.67 million | Fiscal year 2021: $55.21 million | Fiscal year 2020: -$44.23 million | Fiscal year 2019: -$33.12 million | Fiscal year 2018: -$17.13 million | Fiscal year 2017: -$24.98 million | Fiscal year 2016: -$31.14 million | Fiscal year 2015: -$26.72 million | Fiscal year 2014: -$16.36 million | Fiscal year 2013: -$10.89 million | Fiscal year 2012: -$7.20 million | Fiscal year 2011: -$4.73 million | Fiscal year 2010: -$3.19 million | Fiscal year 2009: -$15.51 million.
• Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: June 20, 2026